Health Affairs Paper Featured in A Wall Street Journal Editorial

by | Jan 2, 2026

A recent Wall Street Journal editorial cited our Health Affairs study in its analysis of U.S. drug pricing policy and the innovation effects of Medicare price controls. Our research shows that follow-on oncology drugs are both common and clinically meaningful, with...

Rethinking What We Know About U.S. Drug Prices

by | Sep 24, 2025

Former House Speaker Newt Gingrich recently cited our center’s study in his article on U.S. drug pricing, noting that the research “flips the narrative on its head.” The study compares drug prices in the United States, Canada, Germany, the United Kingdom, France, and...
Scroll to Top